Exploring the clinical application value of peripheral blood T lymphocyte subset in patients with asymptomatic omicron infection.


Journal

European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857

Informations de publication

Date de publication:
05 Jul 2023
Historique:
received: 10 08 2022
accepted: 22 06 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

To investigate the clinical significance and value of peripheral blood T lymphocyte subset in patients with asymptomatic novel coronavirus variant strains infection (OMICRON). A retrospective analysis of 281 patients with asymptomatic OMICRON infection who were admitted and isolated to the Fuyang Second People's Hospital from March to April 2022 was conducted. With 32 normal people as the control group, T lymphocytes of the two groups (CD3 + T, CD3 + CD4 + T, CD3 + CD8 + T) were analyzed and the differences between the two groups were analyzed. CD4 + T lymphocytes between patients with asymptomatic OMICRON infection and patients with mild COVID-19 infection in 2020 were analyzed and compared. Based on CD3 CD4 + T lymphocyte changes, lymphocyte reference range: CD3 CD4 + T lymphocyte count 404-1612/μL. Lower than 404 × 106/μL was defined as lymphocytopenia, patients were divided into the reduced group (138) and the normal group (143). The CT value of novel coronavirus nucleic acid (ORF1ab gene, N gene) and the time of viral shedding were compared between the two groups. Differences in number of CD3 + T cells, CD3 + CD4 + T cells, and CD3 + CD8 + T cells were significant between both groups (P < 0.05), which were significantly higher in the normal population than in the patients with asymptomatic OMICRON infection. There was no significant difference in CD4 + T lymphocytes between patients with asymptomatic OMICRON infection and patients with mild COVID-19 infection in 2020 (P < 0.05). The novel coronavirus nucleic CT value was significantly lower in the CD3CD4 + T lymphocyte-reduced group than in the CD3CD4 + T lymphocyte-normal group (P < 0.05). Moreover, the time of viral shedding was significantly longer in the reduced group compared with the normal group (P < 0.05). The changing characteristics of the peripheral blood T lymphocyte subset count in patients with asymptomatic OMICRON infections can provide an important basis for the diagnosis and outcome of the asymptomatic OMICRON infection.

Identifiants

pubmed: 37408049
doi: 10.1186/s40001-023-01187-3
pii: 10.1186/s40001-023-01187-3
pmc: PMC10320873
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2022 Feb 3;185(3):447-456.e11
pubmed: 35026151
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Cell. 2021 Aug 19;184(17):4401-4413.e10
pubmed: 34265281
J Med Virol. 2022 May;94(5):1777-1779
pubmed: 34964502
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Science. 2021 Dec 24;374(6575):1543-1544
pubmed: 34941398
Immunity. 2021 Sep 14;54(9):2133-2142.e3
pubmed: 34453880
Emerg Microbes Infect. 2022 Dec;11(1):277-283
pubmed: 34951565
Science. 2022 Jan 14;375(6577):183-192
pubmed: 34855510
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):8012-8018
pubmed: 34982465
Nat Med. 2022 Mar;28(3):490-495
pubmed: 35046573
Am J Emerg Med. 2022 Jun;56:158-170
pubmed: 35397357
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1782-1784
pubmed: 34968376
Physiol Res. 2020 Jul 16;69(3):379-388
pubmed: 32469225
Nature. 2021 Dec;600(7887):21
pubmed: 34824381
Postgrad Med J. 2020 Dec;96(1142):753-758
pubmed: 32563999
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466

Auteurs

Tuantuan Li (T)

Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, No. 218 of JiXi Road Hefei, Hefei, 230022, Anhui Province, China.
Department of Clinical Laboratory, The Second People's Hospital of Fuyang City (Fuyang Infectious Disease Clinical College of Anhui Medical University), Fuyang, 236000, Anhui Province, China.

Jing Xu (J)

Department of Clinical Laboratory, Fuyang People's Hospital (Anhui Medical University, Affiliated Fuyang Peoples Hospital), Fuyang, 236000, Anhui Province, China.

Yong Gao (Y)

Department of Clinical Laboratory, The Second People's Hospital of Fuyang City (Fuyang Infectious Disease Clinical College of Anhui Medical University), Fuyang, 236000, Anhui Province, China.

XiaoWu Wang (X)

Department of Clinical Laboratory, The Second People's Hospital of Fuyang City (Fuyang Infectious Disease Clinical College of Anhui Medical University), Fuyang, 236000, Anhui Province, China.

Yuanhong Xu (Y)

Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, No. 218 of JiXi Road Hefei, Hefei, 230022, Anhui Province, China. xyhong1964@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH